Objective: To examine the association between processes measures of diabetes care and time to progression for 4 diabetes complications: coronary artery disease (CAD), stroke, heart failure (HF), and renal disease (RD).
Study Design: This retrospective study followed outcomes from 2003 through 2009 in a cohort of 1797 employees with diabetes who worked for a large US manufacturer and were enrolled in the same health insurance plan.
Methods: Quality of care was measured by consensus standards for testing glycated hemoglobin, lipids, and microalbuminuria. Employees with diabetes who received all 3 measures of care in the baseline year (2003) were compared with those who received less complete testing. Cox proportional hazard regression models were used to assess potential associations between diabetes care and time to complications, controlling for potential confounders.
Results: Observed differences between the 2 groups in time to event were significant for 2 of the 4 complications: HF (hazard ratio [HR] = 0.39, 95% confidence interval [CI], 0.19-0.81; P = .0117) and RD (HR = 0.48, 95% CI, 0.24-0.95; P = .0339) and any of the 4 complications (HR = 0.66, 95% CI, 0.48-0.91; P = .0101). Differences in time to complication for CAD (HR = 0.70, 95% CI, 0.49-1.02; P = .0635) and stroke (HR = 0.63, 95% CI, 0.38-1.07; P = .0891) showed the same trend but were not significant.
Conclusions: Employees with diabetes who received all 3 quality measures experienced fewer complications, risk-adjusting for other factors. These results provide support for the importance of care quality.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045506 | PMC |
Pain Ther
March 2025
Unit of Internal Medicine, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200, 00128, Rome, Italy.
Introduction: Opioid-induced constipation (OIC) is a common side effect of chronic opioid therapy that significantly impacts quality of life and healthcare costs. Naldemedine, a peripherally acting mu-opioid receptor antagonist, has shown efficacy in treating OIC. However, real-world evidence on naldemedine use in the United States is limited, particularly in older adults.
View Article and Find Full Text PDFFront Public Health
March 2025
Health and Wellness Research Group, Department of Family Medicine, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, United Arab Emirates.
Objective: Providing quality healthcare is an essential part of the healthcare system. The high workload and night work associated with healthcare providing may result in work-life imbalance among healthcare professionals (HCPs) and in degradation in the quality of care.
Methods: This cross-sectional study aimed to assess the effects of sociodemographic characteristics and shift work on HCPs' well-being in four large hospitals in the United Arab Emirates using a validated questionnaire.
Int J Equity Health
March 2025
Liverpool School of Tropical Medicine, Department of International Public Health, Pembroke Place, Liverpool, L3 5QA, UK.
Background: There is a growing global burden of non-communicable diseases (NCDs), including diabetes, hypertension and cardiovascular diseases. NCDs constitute a growing public health concern in the Low and Middle Income Countries (LMICs), amplified by rapid urbanisation and urban inequality. Urbanisation and associated inequalities, have profound impacts on healthcare provision and health seeking decision making by marginalised populations living in urban informal settlements.
View Article and Find Full Text PDFPrim Care Diabetes
March 2025
Department of Mathematics, ETSEA, University of Lleida, Lleida, Spain.
Introduction: Type 2 diabetes mellitus (DM2) is one of the main public health threats of the 21st century. Half of the people with DM2 worldwide are not diagnosed. The high prevalence, underdiagnosis and complications of diabetes highlight the need for identifying people at risk.
View Article and Find Full Text PDFExp Clin Endocrinol Diabetes
March 2025
Faculty of Medicine, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Introduction: Little is known about temporal trends in the incidence of male hypogonadism and its correlation with socioeconomic status, which we examined in the present study.
Methods: We extracted data from the Maccabi Health Services computerized database between 2001-2017. The study population included 4,261 men aged 21 to 80 with biochemically proven hypogonadism defined and classified according to the European Male Aging Study criteria.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!